[Spotlight] Date: 2025-06-11 09:27:37 Source: Casper Network Author: People & Interviews Views: 161 times
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
